A pivotal phase III trial investigating adjuvant colorectal cancer vaccine [OncoVAX; Intracel] in patients with stage II colorectal cancer.
Phase of Trial: Phase III
Latest Information Update: 25 Aug 2014
At a glance
- Drugs Colorectal cancer vaccine-Vaccinogen (Primary)
- Indications Colorectal cancer
- Focus Registrational; Therapeutic Use
- Sponsors Intracel Corporation
- 09 Nov 2010 This trial is expected to start before the end of 2010, according to a Vaccinogen media release.
- 08 Mar 2010 Status changed from planning to not yet recruiting, according to Vaccinogen.
- 04 May 2006 New trial record.